U.S. Medical Equipment Stock News

In May 2026, Karman Holdings reported first-quarter fiscal 2026 results with sales of US$151.21 million, returned to profitability, raised full-year revenue guidance to US$720–US$735 million, and highlighted over US$1 billion in contingent multi-year demand commitments from four major space and defense customers. The company also outlined plans to pursue one to two bolt-on acquisitions annually in adjacent areas such as advanced materials and missiles and munitions, signaling an effort to...

If you are wondering whether TKO Group Holdings at around US$194 per share is still a sensible entry point, or if the easy value has already been taken, this article walks through what the current price really reflects. The stock is up 5.8% over the past week and 5.2% over the past month, while year to date it has declined 6.1% and sits on a 23.2% return over the past year. Recent coverage has focused on TKO Group Holdings as a combined combat sports and entertainment company following the...

Universal (UVV) is back in focus after its Board of Directors approved a higher quarterly dividend of $0.83 per share, extending the company’s record to 56 consecutive years of dividend growth. See our latest analysis for Universal. The dividend increase comes as Universal’s share price has edged up, with a 30 day share price return of 6.06% and a year to date share price return of 4.20%. Longer term total shareholder returns of 23.08% over three years and 24.51% over five years point to...

Applied Optoelectronics stock moves after recent performance Applied Optoelectronics (AAOI) has drawn investor attention after recent trading, with the stock closing at US$165.26 and showing very large total returns over the past 3 years alongside mixed shorter term moves. See our latest analysis for Applied Optoelectronics. That recent pullback, with a 1 day share price return down 3.54% and 7 day share price return down 25.93%, sits against a much stronger backdrop that includes a 90 day...

StepStone Group (NasdaqGS:STEP) appointed Taylor Benson as Head of U.S. Defined Contribution. Benson will lead efforts to expand private markets access for U.S. retirement plans. The initiative includes developing retirement focused collective investment trusts across private equity, infrastructure, and private debt. For investors watching NasdaqGS:STEP, this move connects directly to one of the faster evolving parts of asset management: private markets access for retirement plans...

HubSpot (HUBS) is back in focus after a post earnings selloff gave way to renewed buying interest, with investors reacting to solid first quarter results, higher 2026 guidance, and progress on AI monetization. See our latest analysis for HubSpot. Those earnings and guidance headlines have come against a rough year for holders, with the share price down 46.79% year to date and the 1 year total shareholder return down 67.26%. As a result, the recent 7 day share price gain of 13.63% looks more...

Crocs recently benefited from stronger-than-expected first-quarter results across major retailers and its own earlier upbeat 2026 earnings outlook, reinforcing confidence in consumer resilience. This combination of robust sector reports and Crocs’ prior guidance appears to have strengthened investor conviction in the company’s positioning within consumer discretionary footwear. We’ll now examine how this renewed confidence in Crocs’ earnings outlook shapes its broader investment narrative...

A U.S. court recently found that Live Nation Entertainment and its Ticketmaster unit maintained a harmful monopoly over major concert venues. The decision centers on how Live Nation (NYSE:LYV) and Ticketmaster structure ticketing and promotion agreements with venues and promoters. The ruling raises questions about how Live Nation operates its core ticketing and concert promotion business in the U.S. Live Nation runs a large concert and live events business, combining promotion, venue...

Mattel (MAT) is back in focus for investors after recent trading left the stock around $14.89, with returns over the past year and the past 3 months both showing double digit declines. See our latest analysis for Mattel. Recent moves around the US$14.89 share price fit a wider pattern, with short term share price performance roughly flat over the past month. However, the 1 year total shareholder return still shows a clear decline, suggesting that momentum has been fading rather than...

Between January 1 and March 31, 2026, CF Industries Holdings repurchased 155,108 shares for US$15.09 million, completing a total buyback of 3,577,716 shares for US$293.92 million under its May 7, 2025 authorization. This completed buyback, alongside an improving industry outlook for ammonia and low-carbon solutions, highlights how CF Industries is aligning capital returns with emerging demand themes across agriculture, refrigeration, and cleaner energy applications. We will now examine how...

Fresh Del Monte Produce has launched a global campaign with Disney and Pixar’s Toy Story 5, rolling out more than 600 million co-branded pineapple hangtags and banana stickers, alongside in-store activations, digital promotions, and a Barcelona trip sweepstakes tied to the film’s June 19 theatrical release. This collaboration links Fresh Del Monte’s core fruit products with a major family entertainment franchise, potentially strengthening brand recognition and reinforcing its positioning...

Recent performance snapshot Reliance (RS) shares recently closed at US$362.26, with short term moves including a gain of about 1.3% over the past day and a decline of roughly 1.8% over the past week. Looking slightly further out, the stock shows gains of about 8% over the past month and 10.7% over the past 3 months, with a year-to-date return of roughly 22.5% and a 1-year total return near 22.9%. See our latest analysis for Reliance. For investors stepping back from the daily moves,...

Between January 1 and March 31, 2026, Magnolia Oil & Gas completed a share repurchase tranche of 1,235,000 shares for US$32.07 million, bringing total buybacks under its August 6, 2019 program to 50,711,869 shares for US$997.26 million. This substantial reduction in share count, alongside Magnolia’s recent top Zacks Rank and strong Momentum Style Score, highlights how capital returns and positive analyst sentiment are shaping investor perceptions of the company’s outlook. We’ll now examine...

JLens is urging Cloudflare shareholders to withhold votes from select board members at the upcoming annual meeting. The campaign cites an Anti-Defamation League report that criticizes Cloudflare for allegedly providing services to sites spreading violent extremism and terrorism. The move raises questions around Cloudflare's governance, board oversight, and approach to content tied to online extremism. Cloudflare, traded as NYSE:NET, sits at the center of critical internet infrastructure and...

If you are trying to figure out whether 10x Genomics stock is reasonably priced or stretched, the recent share moves and current valuation score give you some useful clues to start with. The stock last closed at US$23.98, with returns of 13.8% over the past week, a decline of 2.5% over the past month, a 44.3% gain year to date, and a 188.2% gain over the past year. Over longer periods, the stock shows declines of 54.5% over three years and 85.8% over five years. Recent news coverage has...

Wondering whether Euronet Worldwide at US$67.78 is a potential bargain or a value trap? This article walks through the key signals you need to weigh before deciding how it fits in your portfolio. The stock has had a tough run, with the share price down 3.0% over the past week, 9.9% over the last month, 8.5% year to date, and 36.3% over the past year. This adds to a 39.8% decline over three years and 54.0% over five years. Recent headlines around Euronet Worldwide have focused on its position...

Oculis Holding secured a formal Special Protocol Assessment agreement from the U.S. FDA for its pivotal Phase 3 PIONEER-1 trial of Privosegtor in optic neuritis. The SPA confirms that the trial design and analysis are acceptable to support a potential future regulatory submission, assuming the study meets its endpoints. Privosegtor already holds FDA Breakthrough Therapy and EMA PRIME designations, positioning it as a potential neuroprotective therapy in optic neuritis. For investors...

Investors may be wondering if SentinelOne at around US$17.97 is still offering value after its recent moves, or if the easy win is already gone. The stock has gained 11.8% over the past week and 25.5% over the last month, while the year to date return sits at 22.7% and the 1 year return shows a decline of 7.4%. Recent coverage has focused on how investors are reassessing cybersecurity stocks and what that could mean for growth expectations, while also debating how much risk is already...

Earlier in May 2026, CACI International secured a US$113.8 million U.S. Navy contract supporting Military Sealift Command integrated business systems, and previously named former L3Harris executive Christopher Monoski as Executive Vice President, Manufacturing to centralize advanced defense technology production. Together, the long-duration Navy work and new manufacturing leadership underscore CACI’s push into more complex, hardware-enabled national security programs that require scaled,...

Provident Financial Services (NYSE:PFS) reported strong Q1 earnings with record fee income. The company highlighted robust commercial loan expansion alongside an uptick in nonperforming loans. Management also pointed to higher technology related expenses as a near term pressure point. For investors tracking NYSE:PFS, the fresh Q1 update adds additional detail beyond the share price alone. The stock most recently closed at $22.15, is up 12.2% year to date and 38.3% over the past year, and...

Bausch + Lomb (BLCO) is in focus after launching PreserVision AREDS3 eye vitamins in the U.S., a new formula that combines established AREDS2 nutrients with an added B vitamin complex for age related macular degeneration. See our latest analysis for Bausch + Lomb. At a share price of US$16.20, recent 90 day share price returns are down 8.22%. However, the 1 year total shareholder return of 44.77% suggests earlier momentum that has cooled in recent months as product launches like PreserVision...

Trane Technologies (NYSE:TT) has launched the BrainBox AI Trane Technologies AI Lab and showroom in Montréal. The new facility is focused on AI driven energy efficiency and sustainability solutions for buildings and cold-chain systems. The launch builds on Trane Technologies' recent acquisition of BrainBox AI and expands its work on autonomous HVAC and transport refrigeration technologies. For investors tracking Trane Technologies at a current share price of $451.69, this move indicates a...

Regencell Bioscience Holdings (RGC) is back in focus after multiple securities class action lawsuits and a disclosed DOJ investigation into trading activities raised fresh questions about market manipulation risk and prior disclosures. See our latest analysis for Regencell Bioscience Holdings. Regencell’s share price has been volatile, with a 1 day share price return of 1.44% and a 90 day share price return that is down 18.14%. At the same time, the year to date share price return of 33.35%...

Recent share performance and valuation snapshot Progress Software (PRGS) has drawn fresh attention after a period of mixed share performance, with the stock closing at $29.21 and sitting on a market value of about $1.22b. Over the past week the stock gained 10.77%, while the past month shows a decline of 6.74% and the past 3 months are down 19.80%. Over 1 year, the total return declined 52.77%, with the 3 year and 5 year total returns down 49.52% and 31.33% respectively. At this level,...